Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
Os inibidores das Janus Associated Kinases (JAK) são uma estratégia recente direcionada para o tratamento de diversas patologias como a artrite reumatoide, a psoríase, a alopecia areata e diversos tipos de cancro. Contudo, estes medicamentos estão associados a reações adversas graves, estando suben...
Main Authors: | Manuel Morgado, Daniela Santos, Sofia Mendes |
---|---|
Format: | Article |
Language: | English |
Published: |
Formifarma, LDA.
2017-04-01
|
Series: | Revista Portuguesa de Farmacoterapia |
Subjects: | |
Online Access: | http://farmacoterapia.pt/index.php/rpf/article/view/127 |
Similar Items
-
Janus Associated Kinases Inhibitors in the Pharmacological Thera
by: Daniela Santos1, et al.
Published: (2017-01-01) -
Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
by: Sara Sadeghi, et al.
Published: (2022-10-01) -
Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
by: Wendao Li, et al.
Published: (2022-03-01) -
Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
by: William Damsky, MD, PhD, et al.
Published: (2020-02-01) -
The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
by: Diqin Yan, et al.
Published: (2022-08-01)